Patent details
EP4188389 Title: DAPAGLIFLOZIN FOR USE IN METHODS OF TREATING CHRONIC KIDNEY DISEASE
Basic Information
- Publication number:
- EP4188389
- PCT Application Number:
- EP2021058727
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP217167246
- PCT Publication Number:
- WO2022022865
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- DAPAGLIFLOZIN FOR USE IN METHODS OF TREATING CHRONIC KIDNEY DISEASE
- French Title of Invention:
- DAPAGLIFLOZINE POUR SON UTILISATION DANS DES MÉTHODES DE TRAITEMENT DES MALADIES RÉNALES CHRONIQUES
- German Title of Invention:
- DAPAGLIFLOZIN ZUR VERWENDUNG IN DER BEHANDLUNG VON CHRONISCHEN NIERENERKRANKUNGEN
- SPC Number:
Dates
- Filing date:
- 01/04/2021
- Grant date:
- 17/09/2025
- EP Publication Date:
- 07/06/2023
- PCT Publication Date:
- 03/02/2022
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 17/09/2025
- EP B1 Publication Date:
- 17/09/2025
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 01/04/2041
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 10/09/2025
- Name:
- AstraZeneca AB
- Address:
- Forskargatan 18, 151 85 Södertälje, Sweden (SE)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 22/09/2025
- Address:
- Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
- To:
Inventor
- Name:
- LANGKILDE, Anna Maria
- Address:
- Sweden (SE)
Priority
1
- Priority Number:
- 202063057139 P
- Priority Date:
- 27/07/2020
- Priority Country:
- United States (US)
2
- Priority Number:
- 202063070869 P
- Priority Date:
- 27/08/2020
- Priority Country:
- United States (US)
3
- Priority Number:
- 202063082524 P
- Priority Date:
- 24/09/2020
- Priority Country:
- United States (US)
4
- Priority Number:
- 202063093961 P
- Priority Date:
- 20/10/2020
- Priority Country:
- United States (US)
5
- Priority Number:
- 202063119711 P
- Priority Date:
- 01/12/2020
- Priority Country:
- United States (US)
6
- Priority Number:
- 202163152445 P
- Priority Date:
- 23/02/2021
- Priority Country:
- United States (US)
7
- Priority Number:
- 202163161629 P
- Priority Date:
- 16/03/2021
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 31/70; A61P 31/12;
Publication
European Patent Bulletin
1
- Issue number:
- 202538
- Publication date:
- 17/09/2025
- Description:
- Grant (B1)
2
- Issue number:
- 202543
- Publication date:
- 22/10/2025
- Description:
- Opposition procedure started
3
- Issue number:
- 202543
- Publication date:
- 22/10/2025
- Description:
- Application number/publication number of the divisional application (Art. 76) changed
Annual Fees
- Annual Fee Due Date:
- 30/04/2026
- Annual Fee Number:
- 6
- Annual Fee Amount:
- 66 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|---|---|
| 23/09/2025 | Outgoing Correspondence | 1 |
| 22/09/2025 | Power Of Attorney | 1 |